rDEN2/4delta30(ME) vaccine

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Dengue Fever

Phase 1

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults

CompletedNCT00094705

National Institute of Allergy and Infectious Diseases (NIAID)Dengue Fever

Start: 2005-01-31End: 2006-04-30Updated: 2008-01-21

Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine

CompletedNCT00920517

National Institute of Allergy and Infectious Diseases (NIAID)Dengue Fever

Start: 2009-01-31End: 2010-01-31Updated: 2013-01-03